EUVIMEDEUVIMED entdecken
Crossref

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario

Krishna Pandey, Prabhat Kumar Sinha, Vidyanand Ravi Das, Sanjiva Bimal, Shubhankar K. Singh, Pradeep Das

Clinical medicine. Pathology · 2009

DOI: 10.4137/cpath.s821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical medicine. Pathology, 2009. Verfasst von Krishna Pandey und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visceral leishmaniasis (VL) or Kala-azar is a protozoal disease, which was previously regarded as one of the most neglected tropical diseases. Management of this disease is quite difficult, because it is said to affect the poorest of the poor. Previously Sodium Stibogluconate (SSG) was regarded as the gold standard treatment for VL. But due to the increasing unresponsiveness, to this drug various other drugs were tried and are still being tried. Pentamidine is very toxic and has been discarded of late. Amphotericin B and its lipid formulations are very effective but require hospital admission and monitoring. Oral drugs like Miltefosine have already been launched. An amino glycoside Paromomycin and another oral drug Sitamaquine are in the pipe line. Interferon gamma has been used with discouraging results.

Zitieren

APA

Pandey, K., Sinha, P. K., Das, V. R., Bimal, S., Singh, S. K., & Das, P. (2009). Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario. Clinical medicine. Pathology. https://doi.org/10.4137/cpath.s821

Vancouver

Pandey K, Sinha PK, Das VR, Bimal S, Singh SK, Das P. Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario. Clinical medicine. Pathology. 2009. doi:10.4137/cpath.s821

BibTeX
@article{Pandey2009,
  author = {Pandey, Krishna and Sinha, Prabhat Kumar and Das, Vidyanand Ravi and Bimal, Sanjiva and Singh, Shubhankar K. and Das, Pradeep},
  title = {Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario},
  journal = {Clinical medicine. Pathology},
  year = {2009},
  doi = {10.4137/cpath.s821}
}
Kostenlos starten →